BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30190993)

  • 1. Radiotherapy for liver tumors.
    Keane FK; Tanguturi SK; Zhu AX; Dawson LA; Hong TS
    Hepat Oncol; 2015 Apr; 2(2):133-146. PubMed ID: 30190993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma.
    Kim N; Cheng J; Jung I; Liang J; Shih YL; Huang WY; Kimura T; Lee VHF; Zeng ZC; Zhenggan R; Kay CS; Heo SJ; Won JY; Seong J
    J Hepatol; 2020 Jul; 73(1):121-129. PubMed ID: 32165253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
    Eggert T; Greten TF
    Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis.
    Shui Y; Yu W; Ren X; Guo Y; Xu J; Ma T; Zhang B; Wu J; Li Q; Hu Q; Shen L; Bai X; Liang T; Wei Q
    Radiat Oncol; 2018 Sep; 13(1):188. PubMed ID: 30253783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation.
    Takeda A; Sanuki N; Tsurugai Y; Iwabuchi S; Matsunaga K; Ebinuma H; Imajo K; Aoki Y; Saito H; Kunieda E
    Cancer; 2016 Jul; 122(13):2041-9. PubMed ID: 27062278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis.
    Sapisochin G; Barry A; Doherty M; Fischer S; Goldaracena N; Rosales R; Russo M; Beecroft R; Ghanekar A; Bhat M; Brierley J; Greig PD; Knox JJ; Dawson LA; Grant DR
    J Hepatol; 2017 Jul; 67(1):92-99. PubMed ID: 28257902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of stereotactic body radiation therapy for hepatocellular carcinoma.
    Kimura T; Doi Y; Takahashi S; Kubo K; Imano N; Takeuchi Y; Takahashi I; Nishibuchi I; Murakami Y; Kenjo M; Nagata Y
    Expert Rev Gastroenterol Hepatol; 2020 Apr; 14(4):271-279. PubMed ID: 32223683
    [No Abstract]   [Full Text] [Related]  

  • 8. Stereotactic Body Radiation Therapy for Liver Tumors: Current Status and Perspectives.
    Doi H; Beppu N; Kitajima K; Kuribayashi K
    Anticancer Res; 2018 Feb; 38(2):591-599. PubMed ID: 29374681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Combination of Stereotactic Body Radiation Therapy and Immunotherapy in Primary Liver Tumors.
    Kreidieh M; Zeidan YH; Shamseddine A
    J Oncol; 2019; 2019():4304817. PubMed ID: 31182960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High rate of complete histopathological response in hepatocellular carcinoma patients after combined transarterial chemoembolization and stereotactic body radiation therapy.
    Bauer U; Gerum S; Roeder F; Münch S; Combs SE; Philipp AB; De Toni EN; Kirstein MM; Vogel A; Mogler C; Haller B; Neumann J; Braren RF; Makowski MR; Paprottka P; Guba M; Geisler F; Schmid RM; Umgelter A; Ehmer U
    World J Gastroenterol; 2021 Jun; 27(24):3630-3642. PubMed ID: 34239274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation therapy for liver tumors: ready for inclusion in guidelines?
    Tanguturi SK; Wo JY; Zhu AX; Dawson LA; Hong TS
    Oncologist; 2014 Aug; 19(8):868-79. PubMed ID: 25001265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation and stereotactic body radiotherapy for hepatocellular carcinoma: should they clash or reconcile?
    Rim CH; Lee HY; Kim JS; Kim H
    Int J Radiat Biol; 2021; 97(2):111-119. PubMed ID: 33253598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial.
    Chiang CL; Chiu KWH; Chan KSK; Lee FAS; Li JCB; Wan CWS; Dai WC; Lam TC; Chen W; Wong NSM; Cheung ALY; Lee VWY; Lau VWH; El Helali A; Man K; Kong FMS; Lo CM; Chan AC
    Lancet Gastroenterol Hepatol; 2023 Feb; 8(2):169-178. PubMed ID: 36529152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Stereotactic Body Radiotherapy and Checkpoint Inhibition in Unresectable Hepatocellular Carcinoma: A Potential Synergistic Treatment Strategy.
    Chiang CL; Chan ACY; Chiu KWH; Kong FS
    Front Oncol; 2019; 9():1157. PubMed ID: 31799176
    [No Abstract]   [Full Text] [Related]  

  • 15. Liver-Directed Treatment Options Following Liver Tumor Recurrence: A Review of the Literature.
    Aquina CT; Eskander MF; Pawlik TM
    Front Oncol; 2022; 12():832405. PubMed ID: 35174097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Sapir E; Tao Y; Schipper MJ; Bazzi L; Novelli PM; Devlin P; Owen D; Cuneo KC; Lawrence TS; Parikh ND; Feng M
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):122-130. PubMed ID: 29066120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic Ablative Body Radiotherapy as a Bridge to Liver Transplant for Hepatocellular Carcinoma: Preliminary Results of Başkent University Experience.
    Yavas G; Ayvazoglu Soy EH; Coskun M; Onal C; Boyvat F; Haberal M
    Exp Clin Transplant; 2022 Mar; 20(Suppl 1):39-45. PubMed ID: 35384806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiation therapy for primary liver tumors: An effective liver-directed therapy in the toolbox.
    Roberts HJ; Wo JY
    Cancer; 2022 Mar; 128(5):956-965. PubMed ID: 34847255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is hepatocellular carcinoma complicated with portal vein tumor thrombosis potentially curable by radiotherapy in the form of stereotactic body radiation therapy?
    Srivastava A; Parambath HK; Ramdulari AV; Saxena H; Kumar R; Pandey S; Shalimar ; Gupta S; Jee B
    Int J Radiat Biol; 2022; 98(10):1495-1509. PubMed ID: 35311612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic Body Radiotherapy: Does It Have a Role in Management of Hepatocellular Carcinoma?
    Choi SH; Seong J
    Yonsei Med J; 2018 Oct; 59(8):912-922. PubMed ID: 30187697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.